Skip to main content

Nicotinamide Mononucleotide (NMN)

Abe Yoando Pharma Chief First Japanese Speaker at Swiss Longevity Summit

Gstaad – September 16, 2026 -- Tomonari Abe, President of 295-year-old Abe Yoando Pharma Co., Ltd., has become the first Japanese speaker in the history of the Longevity Investors Conference, running September 14-17, 2026 in Gstaad, Switzerland.

Global longevity market poised to hit $8 trillion by 2030

The healthy longevity sector is projected to reach approximately $8 trillion by 2030, according to a UBS Chief Investment Office research report cited by the company. International investors are increasingly focused on Japan's aging population as a testing ground for longevity science and market validation ahead of other nations.